glp-1 drugs stocks Novo Nordisk Surges 7.3% as FDA Approves First Oral Weight-Loss Drug GLP-1 Drug Market: the rapid
Description
Wegovy is a prescription medication

41 This finding was consistent with oral semaglutide, with mild-to-moderate gastrointestinal adverse events being the most commonly reported events in clinical trials

Commun Med 4 , 137 (2024)

Lancet 2023, 402, 472483

Journal of Hepatology
